XML 34 R22.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT AND RELATED INFORMATION
12 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
SEGMENT AND RELATED INFORMATION

NOTE 16 - SEGMENT AND RELATED INFORMATION

 

The Company provides segment data in accordance with the provisions of ASC 280, “Disclosures about Segments of an Enterprise and Related Information”.

 

The Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.

 

The accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance based on income or loss from operations.

 

Summarized financial information concerning the Company’s reportable segments is shown in the following table:

 

Summarized Segment Financial Information 

               
   Manufacturing and Servicing of Medical  Management of Diagnostic Imaging   
Fiscal 2023:  Equipment  Center  Totals
Net revenues from external customers  $8,260,711   $90,384,390   $98,645,101 
Intersegment net revenues *  $985,833   $     $985,833 
(Loss) Income from operations  $(5,875,126)  $20,664,388   $14,789,262 
Depreciation and amortization  $263,720   $4,276,415   $4,540,135 
Total identifiable assets  $30,892,807   $170,153,612   $201,046,419 
Capital expenditures  $119,571   $4,218,084   $4,337,655 
                
Fiscal 2022:               
Net revenues from external customers  $8,218,804   $89,373,341   $97,592,145 
Intersegment net revenues *  $965,417   $     $965,417 
(Loss) Income from operations  $(4,604,305)  $26,611,487   $22,007,182 
Depreciation and amortization  $263,559   $4,271,677   $4,535,236 
Total identifiable assets  $30,182,037   $169,159,945   $199,341,982 
Capital expenditures  $258,271   $4,374,903   $4,633,174 

   

* Amounts eliminated in consolidation 

 

Export Product Sales

 

The Company’s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting to 14.1% and 48.9% of product sales revenues to third parties for the years ended June 30, 2023 and 2022, respectively.

 

The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries: 

          
   For the Years Ended June 30,
   2023  2022
Dominican Republic         12.0%
Canada   8.5%   0.6%
Germany   4.9%      
United Arab Emirates   0.7%      
Puerto Rico         36.3%
    14.1%   48.9%

 

 

Foreign Service and Repair Fees

 

The Company’s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to 6.4% and 4.4% of consolidated net service and repair fees for the years ended June 30, 2023 and 2022 respectively. Foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:

 

Foreign Service Repair Fees  

       
 

For the Years

Ended June 30,

  2023   2022
Puerto Rico 1.5%   1.5%
Switzerland 0.3    0.3 
Germany 1.6    1.6 
England 0.6    0.6 
United Arab Emirates 0.1    —   
Dominican Republic 0.5    —   
Canada 0.6    —   
Greece 0.3    0.3 
Australia 0.9    0.1 
  6.4%   4.4%

 

 

The Company does not have any material assets outside of the United States.